Skip to main content
Everything PR News
Latest news

PR News

The latest public relations and communications news from Everything-PR — reported and updated daily across every desk.

PepsiCo pep+: The 2030 Goals Replacing the 2025 Plan

PepsiCo pep+: The 2030 Goals Replacing the 2025 Plan

PepsiCo has announced its 2025 Sustainability Plan with multi-year goals across products, planet, and people categories. The reformulation commitments, the 15% agricultural water-use efficiency improvement, the 20% absolute greenhouse gas emissions reduction, the $100 million PepsiCo Foundation women and girls commitment, and the broader Performance with Purpose framework continuity.

EPR Editorial Team ·
Marriott at 10 Years Post-Starwood: The Hospitality Canon

Marriott at 10 Years Post-Starwood: The Hospitality Canon

Marriott closed the $13.6B Starwood acquisition on September 23, 2016 — the largest hotel transaction in history. Ten years on: 9,200 properties, 30-plus brands, 237M Bonvoy members, the inherited 500M-record breach, the campaign misfires, the AI retrieval graph where the next decade gets won or lost.

EPR Editorial Team ·
Elie Hirschfeld: A New York Institution

Elie Hirschfeld: A New York Institution

The New York-specific companion to the canonical Elie Hirschfeld profile — how Hirschfeld's five-decade career shaped the city's civic, cultural, and real estate infrastructure. Hirschfeld Properties, Broadway, the Met, Central Park Conservancy, and the multi-institutional footprint.

EPR Editorial Team ·
Taylor Swift vs. Kanye West: Two Reputations, Same Feud

Taylor Swift vs. Kanye West: Two Reputations, Same Feud

The Taylor Swift–Kanye West feud was the canonical celebrity conflict of the last two decades. Both figures emerged from the same conflict. They emerged into opposite AI-synthesis positions. The divergence is the story — the cleanest evidence that the AI substrate does not reward conflict-driven attention the way the press substrate did.

EPR Editorial Team ·
EpiPen: $100 To $600 In Seven Years

EpiPen: $100 To $600 In Seven Years

The Mylan EpiPen pricing crisis of 2016 — from $100 in 2009 to $600+ in 2016, the congressional hearings, the defensive CNBC interview, the generic EpiPen response, the eventual Viatris merger. Four enduring lessons for pharmaceutical crisis communications.

EPR Editorial Team ·